Literature DB >> 29113192

miR-514a-3p functions as a tumor suppressor in renal cell carcinoma.

Lu Jin1,2,3, Yifan Li1,2,3, Zeng Zhang1,2,3, Tao He1,3,4, Jia Hu1,3,4, Jiaju Liu1,3,5, Mingwei Chen2,3, Yaoting Gui3, Shangqi Yang1,3, Xiangming Mao1,3, Yun Chen6, Yongqing Lai1,3.   

Abstract

Renal cell carcinoma (RCC) is the most common type of kidney cancer, and the prognosis of metastatic RCC remains poor with a high rate of recurrence and mortality. A previous study has revealed that microRNA (miRNA), which negatively regulates protein expression, serves a role of oncogene or tumor suppressor. The aim of the present study was to investigate the expression and function of miR-514a-3p in RCC. To detect the expression of miR-514a-3p in 32 paired RCC tissues, quantitative polymerase chain reaction (qPCR) was performed. The function of miR-514a-3p in the proliferation, mobility and apoptosis of RCC cells (786-O and ACHN) was assessed by MTT, CCK-8, cell scratch, Transwell, Hoechst 33342 staining and flow cytometry assay. The results of qPCR revealed that miR-514a-3p was significantly downregulated in RCC tissues compared with adjacent normal tissues. Upregulation of miR-514a-3p by transfection of mimics suppressed RCC cell proliferation, migration and invasion, and induced cell apoptosis. The results revealed that miR-514a-3p was significantly downregulated in RCC and may serve a role as tumor suppressor in RCC. Further studies are required, focusing on the possibility of using miR-514a-3p as a biomarker for RCC as well as the pathway of miR-514a-3p in RCC.

Entities:  

Keywords:  miR-514a-3p; microRNA; renal cell carcinoma; tumor suppressor

Year:  2017        PMID: 29113192      PMCID: PMC5661369          DOI: 10.3892/ol.2017.6855

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  26 in total

Review 1.  Many ways to generate microRNA-like small RNAs: non-canonical pathways for microRNA production.

Authors:  Keita Miyoshi; Tomohiro Miyoshi; Haruhiko Siomi
Journal:  Mol Genet Genomics       Date:  2010-07-02       Impact factor: 3.291

2.  miR-149 promotes epithelial-mesenchymal transition and invasion in nasopharyngeal carcinoma cells.

Authors:  Zhaohui Luo; Liyang Zhang; Zheng Li; Chen Jiang; Yafei Dai; Xiaoping Liu; Ying Zheng; Haibo Yu; Juanjuan Xiang; Guiyuan Li
Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban       Date:  2011-07

3.  MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma.

Authors:  Zhengming Su; Duqun Chen; Enpu Zhang; Yifan Li; Zuhu Yu; Min Shi; Zhimao Jiang; Liangchao Ni; Shangqi Yang; Yaoting Gui; Jiongxian Ye; Yongqing Lai
Journal:  Mol Med Rep       Date:  2015-03-17       Impact factor: 2.952

4.  The functional significance of miR-1 and miR-133a in renal cell carcinoma.

Authors:  Kazumori Kawakami; Hideki Enokida; Takeshi Chiyomaru; Shuichi Tatarano; Hirofumi Yoshino; Ichiro Kagara; Takenari Gotanda; Tokushi Tachiwada; Kenryu Nishiyama; Nijiro Nohata; Naohiko Seki; Masayuki Nakagawa
Journal:  Eur J Cancer       Date:  2012-04       Impact factor: 9.162

5.  Tumour-suppressive microRNA-29s directly regulate LOXL2 expression and inhibit cancer cell migration and invasion in renal cell carcinoma.

Authors:  Rika Nishikawa; Takeshi Chiyomaru; Hideki Enokida; Satoru Inoguchi; Tomoaki Ishihara; Ryosuke Matsushita; Yusuke Goto; Ichiro Fukumoto; Masayuki Nakagawa; Naohiko Seki
Journal:  FEBS Lett       Date:  2015-06-19       Impact factor: 4.124

Review 6.  EAU guidelines on renal cell carcinoma: 2014 update.

Authors:  Borje Ljungberg; Karim Bensalah; Steven Canfield; Saeed Dabestani; Fabian Hofmann; Milan Hora; Markus A Kuczyk; Thomas Lam; Lorenzo Marconi; Axel S Merseburger; Peter Mulders; Thomas Powles; Michael Staehler; Alessandro Volpe; Axel Bex
Journal:  Eur Urol       Date:  2015-01-21       Impact factor: 20.096

7.  Downregulation of miR-30c promotes renal fibrosis by target CTGF in diabetic nephropathy.

Authors:  Jinyang Wang; Lijun Duan; Tiankang Guo; Yanbin Gao; Limin Tian; Jing Liu; Shaocheng Wang; Jinkui Yang
Journal:  J Diabetes Complications       Date:  2015-12-17       Impact factor: 2.852

8.  MicroRNA21 promotes interstitial fibrosis via targeting DDAH1: a potential role in renal fibrosis.

Authors:  Xiu-Juan Liu; Quan Hong; Zhen Wang; Yan-yan Yu; Xin Zou; Li-hong Xu
Journal:  Mol Cell Biochem       Date:  2015-10-12       Impact factor: 3.396

9.  Expression and functional role of miR-29b in renal cell carcinoma.

Authors:  Yi Xu; Jianyong Zhu; Zhangming Lei; Lijun Wan; Xiuwen Zhu; Feng Ye; Yanyue Tong
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 10.  MicroRNAs in renal cell carcinoma: a systematic review of clinical implications (Review).

Authors:  Ming Li; Ying Wang; Yongsheng Song; Renge Bu; Bo Yin; Xiang Fei; Qizhen Guo; Bin Wu
Journal:  Oncol Rep       Date:  2015-02-13       Impact factor: 3.906

View more
  3 in total

1.  Human Oral Mucosa Stem Cells Increase Survival of Neurons Affected by In Vitro Anoxia and Improve Recovery of Mice Affected by Stroke Through Time-limited Secretion of miR-514A-3p.

Authors:  Paula Stančin; Min Suk Song; Ivan Alajbeg; Dinko Mitrečić
Journal:  Cell Mol Neurobiol       Date:  2022-09-09       Impact factor: 4.231

2.  Long non‑coding RNA LUCAT1 contributes to cisplatin resistance by regulating the miR‑514a‑3p/ULK1 axis in human non‑small cell lung cancer.

Authors:  Qiming Shen; Zhe Xu; Shun Xu
Journal:  Int J Oncol       Date:  2020-08-07       Impact factor: 5.650

3.  MicroRNA Expression Profiling in Hydatidiform Mole for the Prediction of Postmolar GTN : MicroRNA Profile in Postmolar GTN.

Authors:  Chinachote Teerapakpinyo; Wilasinee Areeruk; Patou Tantbirojn; Vorapong Phupong; Shanop Shuangshoti; Ruangsak Lertkhachonsuk
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.